Research - , ,
JULZ PHARMA IDENTIFIES AND SOLICITS TECHNOLOGY PRIOR INFLECTION POINT IN US AND EUROPE FOR CHINA RIGHTSJulz Pharma leverages the experience and expertise of its management team in dealings with Chinese partners and marketAn emphasis on InnovationA bridge between China and advanced technology companies in the US and EUProvides all aspects of partnering activities and end to end R&D Strategy, including fund raising, due diligence, drug/device development and licensing, M&A negotiationsHeadquartered in the U.S.Operates under standard U.S. legal terms and conditionsStrong understanding of the U.S. and China markets
Gmail
Mobile Friendly